Improving the lives of people living with Parkinson’s.

To develop commercially scalable manufacturing process for spinning spider silk.

3D laser spectrometer and single shot hyperspectral imaging.

building a scalable, modular and flexible quantum computing platform.

Mining large digital pathology datasets through a web platform that can manage a crowd sourced approach to annotation.

First commercial producer of sustainable, guilt-free meat.

Malaria vaccine development.

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

DNA assembly.

Platform technology based on NG capture-c technique computational pipelines and experimental know-how.

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Development and commercialisation of quantum physics, acceleration and optimisation software for intelligent computational R&D.

Software and patented approach to differential diagnosis of cognitive diseases

A biologics company with a mission to treat a range of autoimmune and inflammatory disorders.

High performance quantum computing

To develop compound libraries based on the asymmetric synthesis methodolofies.

Strategy gaming and consultancy

Focus on the synthesis of natural products.

OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.

OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.